158 related articles for article (PubMed ID: 7507463)
41. Heterogeneity of hepatic acetaldehyde adducts in guinea-pigs after chronic ethanol administration: an immunohistochemical analysis with monoclonal and polyclonal antibodies against acetaldehyde-modified protein epitopes.
Yokoyama H; Ishii H; Nagata S; Moriya S; Ito T; Kato S; Tsuchiya M
Alcohol Alcohol Suppl; 1993; 1A():91-7. PubMed ID: 7511382
[TBL] [Abstract][Full Text] [Related]
42. Prognosis for the patients with alcoholic and nonalcoholic liver disease.
Colić-Cvrlje V; Naumovski-Mihalić S; Prskalo M; Colić A; Cvjeticanin B; Sabarić B
Coll Antropol; 2000 Jun; 24(1):249-52. PubMed ID: 10895552
[TBL] [Abstract][Full Text] [Related]
43. IgAs against acetaldehyde-modified red cell protein as a marker of ethanol consumption in male alcoholic subjects, moderate drinkers, and abstainers.
Hietala J; Koivisto H; Latvala J; Anttila P; Niemelä O
Alcohol Clin Exp Res; 2006 Oct; 30(10):1693-8. PubMed ID: 17010136
[TBL] [Abstract][Full Text] [Related]
44. Differential depletion of carotenoids and tocopherol in liver disease.
Leo MA; Rosman AS; Lieber CS
Hepatology; 1993 Jun; 17(6):977-86. PubMed ID: 8514270
[TBL] [Abstract][Full Text] [Related]
45. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis.
Li J; Rosman AS; Leo MA; Nagai Y; Lieber CS
Hepatology; 1994 Jun; 19(6):1418-23. PubMed ID: 8188171
[TBL] [Abstract][Full Text] [Related]
46. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.
Ribeiro PS; Cortez-Pinto H; Solá S; Castro RE; Ramalho RM; Baptista A; Moura MC; Camilo ME; Rodrigues CM
Am J Gastroenterol; 2004 Sep; 99(9):1708-17. PubMed ID: 15330907
[TBL] [Abstract][Full Text] [Related]
47. Detection and localization of protein-acetaldehyde adducts in rat brain after chronic ethanol treatment.
Upadhya SC; Ravindranath V
Alcohol Clin Exp Res; 2002 Jun; 26(6):856-63. PubMed ID: 12068255
[TBL] [Abstract][Full Text] [Related]
48. Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis.
Akyol G; Erdem O; Yilmaz G
Saudi Med J; 2005 Dec; 26(12):1904-10. PubMed ID: 16380770
[TBL] [Abstract][Full Text] [Related]
49. Cross-reactivity of antibodies raised against acetaldehyde adducts of protein with acetaldehyde adducts of phosphatidyl-ethanolamine: possible role in alcoholic cirrhosis.
Trudell JR; Ardies CM; Anderson WR
Mol Pharmacol; 1990 Nov; 38(5):587-93. PubMed ID: 2233695
[TBL] [Abstract][Full Text] [Related]
50. Morphology of alcoholic liver disease.
Lefkowitch JH
Clin Liver Dis; 2005 Feb; 9(1):37-53. PubMed ID: 15763228
[TBL] [Abstract][Full Text] [Related]
51. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
[TBL] [Abstract][Full Text] [Related]
52. Clinical significance of hepatitis GB virus C infection in alcoholic liver disease.
Tsutsumi M; Sawada M; Takase S; Chen WB; Ueshima Y; Tsuchishima M; Shimanaka K; Itoh T; Kawahara H
Alcohol Clin Exp Res; 1997 Dec; 21(9):1722-5. PubMed ID: 9438537
[TBL] [Abstract][Full Text] [Related]
53. [Alcoholic liver disease].
Waluga M; Hartleb M
Wiad Lek; 2003; 56(1-2):61-70. PubMed ID: 12901271
[TBL] [Abstract][Full Text] [Related]
54. Humoral immune response to acetaldehyde adducts in alcoholic patients.
Hoerner M; Behrens UJ; Worner T; Lieber CS
Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):3-12. PubMed ID: 3099350
[TBL] [Abstract][Full Text] [Related]
55. Giant mitochondria in hepatocytes: a diagnostic hint for alcoholic liver disease.
Bruguera M; Bertran A; Bombi JA; Rodes J
Gastroenterology; 1977 Dec; 73(6):1383-7. PubMed ID: 913978
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical determination of hepatic cytochrome P-4502E1 in formalin-fixed, paraffin-embedded sections.
Cohen PA; Mak KM; Rosman AS; Kessova I; Mishin VM; Koivisto T; Lieber CS
Alcohol Clin Exp Res; 1997 Sep; 21(6):1057-62. PubMed ID: 9309318
[TBL] [Abstract][Full Text] [Related]
57. Hepatic expression of c-Myb in chronic human liver disease.
Kitada T; Seki S; Nakatani K; Kawada N; Kuroki T; Monna T
Hepatology; 1997 Dec; 26(6):1506-12. PubMed ID: 9397991
[TBL] [Abstract][Full Text] [Related]
58. Ethanol induces the production of antibodies to acetaldehyde-modified epitopes in rats.
Worrall S; De Jersey J; Shanley BC; Wilce PA
Alcohol Alcohol; 1989; 24(3):217-23. PubMed ID: 2474297
[TBL] [Abstract][Full Text] [Related]
59. Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression.
Ikura Y; Ohsawa M; Suekane T; Fukushima H; Itabe H; Jomura H; Nishiguchi S; Inoue T; Naruko T; Ehara S; Kawada N; Arakawa T; Ueda M
Hepatology; 2006 Mar; 43(3):506-14. PubMed ID: 16496325
[TBL] [Abstract][Full Text] [Related]
60. [Acetaldehyde adducts in the cerebral cortex of long-term ethanol-fed mice].
Nakano T; Nakamura K; Suwaki H; Itoh M; Ameno K; Itoh K; Iwahashi K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 1999 Dec; 34(6):549-57. PubMed ID: 10659608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
